Health Science Daily

The procedure involves removing part or all of breast tissue depending on condition severity.

The details vary more than most people realize.

Stem cell transplants are often used after intensive therapies for certain cancers, blood disorders, and autoimmune conditions.

The role these cells play afterward is what makes the process so important.

The former Disney star recently underwent cancer screening after concerns linked to her family history.

What happened next left her facing questions she wasn't expecting.

The journalist was diagnosed with breast cancer in 2022 after additional testing followed a routine screening.

One part of her experience is prompting many people to look at screenings differently.

Despite having normal mammogram results, Kim Munn’s elevated breast cancer risk score prompted additional screening that ultimately led to early detection. This early intervention played a crucial role in her treatment journey, which included surgery and 12 rounds of chemotherapy. Today, she is reported to be doing well after completing her treatment successfully.

Source: Entertainment health coverage and publicly shared medical journey reports
Disclaimer: This content is for informational purposes only and should not be considered medical guidance.

Mastectomy is a surgical procedure used in breast cancer treatment where part or all of the breast is removed depending on the severity and spread of the disease. While the idea of surgery can feel overwhelming, it is often a life-saving step that helps reduce cancer risk and improve long-term outcomes.

Source: American Cancer Society, NHS, Johns Hopkins Medicine
Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.

Professor Richard Scolyer AO dedicated his life to transforming cancer care and improving survival for patients around the world. As one of Australia's most respected melanoma pathologists, his groundbreaking research helped establish immunotherapy approaches that have saved countless lives.

When he was diagnosed with aggressive glioblastoma in 2023, Scolyer approached his own illness with the same courage and scientific curiosity that defined his career. He became the first participant in an innovative personalized treatment strategy, openly sharing his journey to help advance knowledge of one of the world's most challenging brain cancers.

Although he passed away peacefully in June 2026, his impact continues through the patients he helped, the researchers he inspired, and the medical advances his work made possible. His story remains a powerful example of resilience, compassion, and a commitment to helping others even in the face of immense personal adversity.

Fact: Professor Richard Scolyer was jointly named Australian of the Year in 2024 for his contributions to melanoma research and cancer treatment innovation.

Source: Nature Medicine, Australian of the Year Awards, Melanoma Institute Australia, 2025–2026.

Disclaimer: This content is for educational and awareness purposes only and should not be considered medical advice.

Teddi Mellencamp has shared one of the most encouraging updates of her cancer journey so far. According to her doctors, recent scans show no evidence of tumors remaining in her body, a remarkable milestone after battling Stage 4 melanoma.

Originally diagnosed with Stage 2 melanoma in 2022, her cancer later spread to her brain and lungs. She underwent multiple surgeries and intensive treatments to remove tumors and control the disease. Despite these challenges, she continued to face each setback with determination and transparency, sharing her journey publicly to raise awareness.

While Teddi remains classified as Stage 4 and continues monthly immunotherapy treatments, doctors have now extended the time between her scans from monthly to every three to four months. For her, this represents not just medical progress but also a chance to breathe a little easier and focus on living life beyond cancer.

Fact: Teddi Mellencamp's latest scans reportedly show no visible evidence of tumors, though she continues maintenance immunotherapy as part of her Stage 4 melanoma treatment plan.

Source: Public statements by Teddi Mellencamp, media interviews, and reported health updates, 2026.

Disclaimer: This content is for informational and awareness purposes only and is not intended as medical advice. Individual cancer outcomes and treatment plans vary.

Diagnosed with Stage 3 angioimmunoblastic T-cell lymphoma in 2022, Sam Neill initially believed the swollen glands in his neck were nothing serious. Even doctors first suspected lingering effects of COVID. But further testing revealed a rare and aggressive form of blood cancer.

The Jurassic Park star underwent several rounds of chemotherapy, but unfortunately the treatment eventually stopped working. Facing limited options, Neill turned to CAR T-cell therapy, an advanced immunotherapy that reprograms a patient's own immune cells to target cancer. The treatment proved successful, and he later announced that scans showed no evidence of cancer in his body.

Today, Sam uses his experience to advocate for greater access to innovative cancer treatments while encouraging others facing serious illness not to lose hope. His journey highlights both the power of medical advances and the resilience of the human spirit.

Fact: Sam Neill achieved remission after receiving CAR T-cell therapy for Stage 3 angioimmunoblastic T-cell lymphoma after conventional chemotherapy failed.

Source: 7News Australia, People Magazine, American Cancer Society, 2026.

Disclaimer: This content is for educational and awareness purposes only and is not intended as medical advice. Treatment outcomes vary between individuals.

Maria Menounos was diagnosed with a Stage 2 pancreatic neuroendocrine tumor in 2023 after ongoing abdominal pain and bloating prompted further investigation beyond routine medical testing

When standard evaluations failed to provide answers, a full body MRI identified the tumor, leading to a successful ten hour surgery that removed the mass along with part of her pancreas, spleen, lymph nodes, and a large fibroid

Now cancer free, she advocates for proactive health management, early detection, and listening to persistent symptoms, encouraging people to take an active role in their healthcare decisions and seek further evaluation when necessary

Fact source Public interviews, health advocacy campaigns, and reports regarding Maria Menounos’ pancreatic neuroendocrine tumor diagnosis and recovery journey

Disclaimer This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, screening recommendations, or treatment.